primary biliary cholangitis
Conditions
Interventions
Sponsors
Longhua Hospital, Shanghai University of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) person signing informed consent; (2) male or female aged 18-65 years; (3) syndrome differentiation of traditional Chinese medicine for liver and kidney yin deficiency and stasis; (4) patients whose clinical diagnosis of Western medicine conforms to the PBC diagnostic standard and belongs to stage 2 and 3.
Exclusion criteria
Exclusion criteria: (1) combined with drug-induced liver injury, autoimmune hepatitis A, B, C, e, etc. (2) patients with serious primary diseases of heart, brain, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract, or psychosis; (3) creatinine (CR) is higher than the upper limit of normal value; (4) those who use drugs to lose weight; (5) an alcoholic or drug addict; (6) pregnant women, lactating women or those who prepare for pregnancy in the near future and those who use estrogen for contraception; (7) those who are allergic to a variety of drugs, this medicine or its components; (8) the patient is in critical condition, and it is difficult to make accurate evaluation on the effectiveness and safety of the new drug; (9) patients are not willing to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical efficiency;Clinical symptom score ;liver function;Four items of liver fibrosis ;AMA;AMA-M2;GLOBE-Score;APRI??;Fibrotouch; | — |
Countries
China
Contacts
Public ContactXing Lianjun
Longhua Hospital, Shanghai University of traditional Chinese Medicine
Outcome results
None listed